Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Insulin resistance in treated HIV infection.

Feeney ER, Mallon PW.

Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):443-58. doi: 10.1016/j.beem.2010.11.002. Review.

PMID:
21663838
2.

Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.

Guaraldi G, Zona S, Orlando G, Carli F, Stentarelli C, Luzi K, Garlassi E, Menozzi M, Bagni P, Adorni F.

Clin Drug Investig. 2011 Nov 1;31(11):759-67. doi: 10.2165/11593920-000000000-00000.

PMID:
21919542
3.

Insulin resistance in the HIV-infected population: the potential role of mitochondrial dysfunction.

Shikuma CM, Day LJ, Gerschenson M.

Curr Drug Targets Infect Disord. 2005 Sep;5(3):255-62. Review.

PMID:
16181144
5.

Insulin resistance and HIV infection: a review.

Aboud M, Elgalib A, Kulasegaram R, Peters B.

Int J Clin Pract. 2007 Mar;61(3):463-72. Review.

PMID:
17313615
6.

Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.

Dejkhamron P, Unachak K, Aurpibul L, Sirisanthana V.

J Pediatr Endocrinol Metab. 2014 May;27(5-6):403-12. doi: 10.1515/jpem-2013-0253.

PMID:
24259240
7.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
8.

Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.

Holstein A, Plaschke A, Egberts EH.

Exp Clin Endocrinol Diabetes. 2001;109(8):389-92. Review.

PMID:
11748485
9.
10.

Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy.

Duong M, Petit JM, Piroth L, Grappin M, Buisson M, Chavanet P, Hillon P, Portier H.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):245-50.

PMID:
11464143
11.

Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.

Leonard EG, McComsey GA.

Infect Dis Clin North Am. 2005 Sep;19(3):713-29. Review.

PMID:
16102657
12.

Metabolic complications of antiretroviral therapy in children.

Leonard EG, McComsey GA.

Pediatr Infect Dis J. 2003 Jan;22(1):77-84. Review.

PMID:
12544413
13.

Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.

Grinspoon SK.

Am J Med. 2005 Apr;118 Suppl 2:23S-28S. Review.

PMID:
15903292
14.

Glucose disorders associated with HIV and its drug therapy.

Hardy H, Esch LD, Morse GD.

Ann Pharmacother. 2001 Mar;35(3):343-51. Review.

PMID:
11261533
15.

Disorders of glucose metabolism in patients infected with human immunodeficiency virus.

Dubé MP.

Clin Infect Dis. 2000 Dec;31(6):1467-75. Epub 2000 Nov 29. Review.

16.

Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.

Veloso S, Peraire J, Viladés C, López-Dupla M, Escoté X, Olona M, Garcia-Pardo G, Gómez-Bertomeu F, Soriano A, Sirvent JJ, Vidal F.

Curr Pharm Des. 2010 Oct;16(30):3379-89. Review.

PMID:
20687887
17.

Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment.

Giralt M, Díaz-Delfín J, Gallego-Escuredo JM, Villarroya J, Domingo P, Villarroya F.

Curr Pharm Des. 2010 Oct;16(30):3371-8. Review.

PMID:
20687888
18.

Endothelial markers and HIV infection in the era of highly active antiretroviral treatment.

de Larrañaga GF, Bocassi AR, Puga LM, Alonso BS, Benetucci JA.

Thromb Res. 2003 May 1;110(2-3):93-8.

PMID:
12893023
19.
20.

The metabolic puzzle during the evolution of HIV infection.

Salas-Salvadó J, García-Lorda P.

Clin Nutr. 2001 Oct;20(5):379-91. Review.

PMID:
11534932
Items per page

Supplemental Content

Write to the Help Desk